Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 3
1965 46
1966 74
1967 87
1968 114
1969 137
1970 206
1971 200
1972 268
1973 315
1974 354
1975 355
1976 240
1977 252
1978 233
1979 250
1980 185
1981 200
1982 221
1983 222
1984 273
1985 330
1986 310
1987 272
1988 268
1989 320
1990 275
1991 258
1992 280
1993 278
1994 264
1995 263
1996 272
1997 290
1998 371
1999 291
2000 290
2001 308
2002 312
2003 255
2004 288
2005 317
2006 316
2007 349
2008 359
2009 290
2010 277
2011 342
2012 340
2013 361
2014 328
2015 367
2016 350
2017 390
2018 362
2019 342
2020 347
2021 307
2022 342
2023 337
2024 325
2025 325
2026 190

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,446 results

Results by year

Filters applied: . Clear all
Page 1
Ampicillin and gentamicin prophylaxis is superior to ampicillin alone in patients with prelabor rupture of membranes at term: the results of a randomized clinical trial.
Abu Shqara R, Glikman D, Goldinfeld G, Braude O, Assy S, Hassan D, Sgayer I, Ganem N, Shasha-Lavsky H, Yefet E, Matanis M, Lowenstein L, Frank Wolf M. Abu Shqara R, et al. Am J Obstet Gynecol. 2025 Oct;233(4):321.e1-321.e10. doi: 10.1016/j.ajog.2025.03.011. Epub 2025 Mar 12. Am J Obstet Gynecol. 2025. PMID: 40086563 Clinical Trial.
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial.
Song Z, Zhou L, Wang W, Lan C, Tang T, Xie J, Fan H, Wang X, Zuo X, Zhu Y, Liu C, Gu Y, Feng H, Gao X, Zhang Q, Zhang H, Chen J, Geng G, Ma Z; EVEREST-HP Study Group. Song Z, et al. Lancet Infect Dis. 2026 Jan;26(1):101-110. doi: 10.1016/S1473-3099(25)00438-4. Epub 2025 Sep 10. Lancet Infect Dis. 2026. PMID: 40945526 Clinical Trial.
A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP).
Li J, Wei F, Xiang P, Tang Z, Ding L, Chen LF, Losada M, Iamboliyska Z, Sun F, Zhu M, Guo X, Du X, Chen C, Bruno C, Koseoglu S, Young K, Zhou M, Qu J. Li J, et al. Int J Infect Dis. 2025 Apr;153:107357. doi: 10.1016/j.ijid.2024.107357. Epub 2024 Dec 12. Int J Infect Dis. 2025. PMID: 39674398 Free article. Clinical Trial.
Amoxicillin vs. placebo to reduce symptoms in children with group A streptococcal pharyngitis: a randomized, multicenter, double-blind, non-inferiority trial.
Gualtieri R, Verolet C, Mardegan C, Papis S, Loevy N, Asner S, Rohr M, Llor J, Heininger U, Lacroix L, Pittet LF, Posfay-Barbe KM. Gualtieri R, et al. Eur J Pediatr. 2024 Nov;183(11):4773-4782. doi: 10.1007/s00431-024-05705-1. Epub 2024 Aug 31. Eur J Pediatr. 2024. PMID: 39215861 Free PMC article. Clinical Trial.
16,446 results
You have reached the last available page of results. Please see the User Guide for more information.